The terms of the agreement were not disclosed. The transaction closed on 20 December 2013, with the transfer effective on 1 January 2014.

The sale of this sales division in France is consistent with Cargill Animal Nutrition’s strategy of sharpening its focus on its core animal nutrition solutions and premix activities and concentrating on product lines where it can bring the most value to customers.

The two firms have agreed that Cargill’s Provimi business will continue to manufacture ruminant bolus products for Bimeda, activities that are core to Cargill’s animal nutrition business in France.

“By exiting this non-core business we are able to better position our business in France to capitalize on growth opportunities in the animal nutrition industry,” said Mark Poeschl, vice president and group director for Cargill’s Provimi business. “In addition, Bimeda offers better opportunities for Zootech employees because it is better aligned with Bimeda’s core business activities.”